Publication | Closed Access

Randomized phase III study comparing best supportive care to biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation therapy oncology group (RTOG) 97-13

Radiation MedicineOncologyRadiation TherapyBreast IrradiationRadiation EffectBreast CancerPhase Iii StudyRadiation EffectsMedicineRadiation Oncology